C

Ceptur Therapeutics

6 employees

Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2008

Funding rounds raised

Total raised

$75M

from 7 investors over 7 rounds

C

Ceptur Therapeutics raised $75M on January 19, 2022

Investors: Perceptive Advisors, venBio Partners, Qiming Venture Partners, LifeSci Venture Partners, Bristol-Myers Squibb, UK and Affinity Asset Advisors

C

Ceptur Therapeutics raised $6.2M on August 13, 2020

Investors: Affinity Asset Advisors

FAQ